- Report
- October 2024
- 199 Pages
Global
From €3522EUR$3,545USD£2,928GBP
€3913EUR$3,939USD£3,254GBP
- Report
- November 2023
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 212 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- August 2024
- 170 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- January 2024
- 200 Pages
Global
From €4123EUR$4,150USD£3,428GBP
- Report
- December 2023
- 150 Pages
Global
From €3609EUR$3,633USD£3,001GBP
€5156EUR$5,190USD£4,287GBP
- Report
- January 2024
- 157 Pages
Global
From €4620EUR$4,650USD£3,841GBP
- Report
- October 2024
- 197 Pages
Global
From €3522EUR$3,545USD£2,928GBP
€3913EUR$3,939USD£3,254GBP
- Report
- October 2024
- 197 Pages
Global
From €3522EUR$3,545USD£2,928GBP
€3913EUR$3,939USD£3,254GBP
- Report
- October 2024
- 181 Pages
Global
From €3522EUR$3,545USD£2,928GBP
€3913EUR$3,939USD£3,254GBP
- Report
- October 2024
- 198 Pages
Global
From €3522EUR$3,545USD£2,928GBP
€3913EUR$3,939USD£3,254GBP
- Report
- October 2024
- 182 Pages
Global
From €3522EUR$3,545USD£2,928GBP
€3913EUR$3,939USD£3,254GBP
- Report
- October 2024
- 191 Pages
Global
From €3522EUR$3,545USD£2,928GBP
€3913EUR$3,939USD£3,254GBP
- Report
- February 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- December 2023
- 152 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- November 2023
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 282 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 182 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- April 2024
- 138 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- June 2024
- 215 Pages
Global
From €2275EUR$2,290USD£1,892GBP
The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy.
The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more